Antineoplastic Agents

Products & Service

• An anthracycline mechanism which intercalates into DNA and inhibits topoisomerase II, promoting the generation of free radicals that induce tumor cell death. • Demonstrates a longstanding, evidence-based role in treating breast cancer, lymphomas, sarcomas, and other malignancies. • Delivered via IV in...

Our products include: Atosiban Cabazitaxel Cebrium(R) Cerebrolysin(R) Dacepton(R) Dexmedetomidine Docetaxel Fulvestrant MemoProve(R) Oxytocin Paclitaxel Pemetrexed Tachyben(R) Terlipressin

As a cornerstone drug for the treatment of multiple myeloma, Bortezomib is used throughout the induction, consolidation and maintenance therapies for myeloma. In 2020, Bortezomib was recommended as a first-line drug for the full management of multiple myeloma in the Guidelines for Diagnosis and Treatm...

Azacitidine Drug of choice in adult patients who are not considered candidates for hematopoietic stem cell transplantation and who suffer from: myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia. Each vial contains azacitidine 100 mg as a sterile lyophilized powder for ...

• Cytotoxic Injection (Liquid , Lyophilized) • ONCOLOGY  • CYTOTOXIC API • EU GMP  • JGMP (Japan) • KGMP (Korea) • PIC/S

Anti cancer

Abiraterone Acetate Tablets USP 250 mg is a key androgen biosynthesis inhibitor used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC).

Mechanism of Action (MOA): Abiraterone selectively inhibits CYP17, ...

Monomethyl auristatin E, abbreviated as MMAE, is a synthetic antitumor agent. Due to its toxicity, it cannot be used as a drug alone but is instead conjugated to monoclonal antibodies (mAb). It is an effective antimitotic agent derived from dolastatin, a peptide found in the marine mollusk Dolabella auricu...

Monomethyl auristatin E, abbreviated as MMAE, is a synthetic antitumor agent. Due to its toxicity, it cannot be used as a drug alone but is instead conjugated to monoclonal antibodies (mAb). It is an effective antimitotic agent derived from dolastatin, a peptide found in the marine mollusk Dolabella auricu...

China approved

under Development

• Stabilizes microtubules to obstruct cell division by preventing spindle disassembly. • Supported by extensive clinical evidence in treating breast, ovarian, lung, and other solid tumors. • Administered via intravenous infusion, integrating well with established chemotherapy regimens.

• Disrupts tumor DNA through crosslink formation to impede cell replication. • Widely validated in the treatment of various solid malignancies, including ovarian and lung cancers. • Administered via infusion to integrate seamlessly into contemporary oncology protocols. • Exhibits manageable adverse eff...

• High-purity active pharmaceutical ingredient designed for the manufacture of dasatinib-based formulations. • A potent multi-targeted tyrosine kinase inhibitor effective against BCR-ABL and Src family kinases. • Exhibits robust inhibitory activity, making it a critical component in treatments for CML a...

• Facilitates DNA crosslinking to inhibit replication and promote cancer cell apoptosis. • Demonstrates robust efficacy in various solid tumors, including testicular, ovarian, and bladder cancers. • Delivered via infusion, aligning with established oncology treatment protocols. • Often paired with othe...

• A potent taxane agent which stabilizes microtubules to disrupt cell division and promote apoptosis in malignant cells. • Demonstrated efficacy across various cancers including breast, lung, and prostate. • Seamlessly integrated into standard oncology treatment protocols. • Adverse effects are managea...

• An anthracycline derivative which intercalates into DNA and inhibits topoisomerase II, disrupting cancer cell replication. • Demonstrated success in the treatment of breast and other solid tumors through extensive clinical trials. • Delivered via infusion, integrating smoothly into established chemoth...

• Inhibits topoisomerase I to interfere with DNA replication and trigger tumor cell apoptosis. • Clinically validated through extensive studies in metastatic colorectal and other solid tumors. • Delivered via intravenous infusion to integrate seamlessly with established chemotherapy regimens. • Demonst...

• Erlotinib blocks the epidermal growth factor receptor’s tyrosine kinase to suppress tumor cell growth. • Validated efficacy in non-small cell lung cancer (first-line). • Offered in tablet form to facilitate patient-friendly, outpatient treatment. • Underpinned by a wide range of peer-reviewed studies...